Tobacco Policy/Regulatory Factors - Prevention Summary Table
Only one measure per topic is displayed in the summary table. A complete set of measures, where they exist, can be found by following the More Information link in the table below.
![]() |
green - headed in the right direction |
![]() |
red - headed in the wrong direction |
![]() |
black - stable or non-significant change (NSC) |
![]() |
purple - indeterminate |
![]() |
blue - Healthy People 2030 target |
Measure Name | Tobacco Company Marketing Expenditures | Medicaid Insurance Coverage of Tobacco Cessation Treatments |
---|---|---|
Year Range | 1970-2020 | 2008-2022 |
Measure |
Combined cigarette annual advertising and promotional expenditures by the parent companies of the major manufacturers of cigarettes sold in the U.S., adjusted, as reported by manufacturers to the U.S. Federal Trade Commission. Combined smokeless tobacco annual advertising and promotional expenditures by the parent companies of the major manufacturers of smokeless tobacco products in the U.S., adjusted, as reported by manufacturers to the U.S. Federal Trade Commission. |
The number of state Medicaid programs that provide comprehensive insurance coverage of evidence-based tobacco cessation treatments (all seven FDA-approved smoking cessation medications plus individual and group cessation counseling) for standard Medicaid enrollees. The number of state Medicaid programs that provide insurance coverage for individual or group tobacco cessation counseling for standard Medicaid enrollees.1 |
Recent Summary Trend | Falling | Rising |
Recent Summary Trend Year Range | 2016-2020 | 2018-2022 |
Desired Direction | Falling | Rising |
Summary Graph |
![]() |
![]() |
Trends and Most Recent Estimates | In 2020, adjusted combined annual expenditures for cigarette advertising and promotion was $7.8 billion. | In 2022, 20 states provided comprehensive insurance coverage of evidence-based tobacco cessation treatments (seven FDA-approved smoking cessation medications plus individual and group cessation counseling) for all standard Medicaid enrollees. |
Healthy People 2030 Target | No Healthy People Target for this measure. | HP 2030 Target TU-16: 51 U.S. States (including the District of Columbia). |
More Information | Tobacco Company Marketing Expenditures | Medicaid Insurance Coverage of Tobacco Cessation Treatments |
Last Updated | August 2023 | August 2023 |
Measure Name | Medicaid Insurance Coverage of Tobacco Cessation Treatments |
---|---|
Year Range | 2008-2022 |
Measure |
The number of state Medicaid programs that provide comprehensive insurance coverage of evidence-based tobacco cessation treatments (all seven FDA-approved smoking cessation medications plus individual and group cessation counseling) for standard Medicaid enrollees. The number of state Medicaid programs that provide insurance coverage for individual or group tobacco cessation counseling for standard Medicaid enrollees.1 |
Recent Summary Trend | Rising |
Recent Summary Trend Year Range | 2018-2022 |
Desired Direction | Rising |
Summary Graph |
![]() |
Trends and Most Recent Estimates | In 2022, 20 states provided comprehensive insurance coverage of evidence-based tobacco cessation treatments (seven FDA-approved smoking cessation medications plus individual and group cessation counseling) for all standard Medicaid enrollees. |
Healthy People 2020 Target | HP 2030 Target TU-16: 51 U.S. States (including the District of Columbia). |
More Information | Medicaid Insurance Coverage of Tobacco Cessation Treatments |
Measure Name | Tobacco Company Marketing Expenditures |
---|---|
Year Range | 1970-2020 |
Measure |
Combined cigarette annual advertising and promotional expenditures by the parent companies of the major manufacturers of cigarettes sold in the U.S., adjusted, as reported by manufacturers to the U.S. Federal Trade Commission. Combined smokeless tobacco annual advertising and promotional expenditures by the parent companies of the major manufacturers of smokeless tobacco products in the U.S., adjusted, as reported by manufacturers to the U.S. Federal Trade Commission. |
Recent Summary Trend | Falling |
Recent Summary Trend Year Range | 2016-2020 |
Desired Direction | Falling |
Summary Graph |
![]() |
Trends and Most Recent Estimates | In 2020, adjusted combined annual expenditures for cigarette advertising and promotion was $7.8 billion. |
Healthy People 2020 Target | No Healthy People Target for this measure. |
More Information | Tobacco Company Marketing Expenditures |